---
$id: https://graph.org.ai/products/commodity/51111815
$type: Product
source: UNSPSC
code: "51111815"
title: "Triptorelin"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Triptorelin

**UNSPSC Code**: 51111815
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gonadotropin-releasing hormone analog and anti-androgen with the molecular formula C64H82N18O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9081Y98W2V, chemically known as luteinizing hormone-releasing factor (pig), 6-d-tryptophan but generally known as triptorelin, which bears US NIH Compound Identifier 16129684. European Medicines Agency schedules Triptorelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11324MIG. The term TRIPTORELIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules triptorelin in its Anatomical Therapeutic Chemical (ATC) Classification. TRIPTORELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule triptorelin under HS 29371900 and SITC 54154. As of Q4 2014, TRIPTORELIN remains the US FDA Preferred Term for this commodity. Triptorelin bears US NLM identifiers UMLS ID C0077275 and NCI Concept Code C1267. SMILES: O=C(N1C(CCC1)C(=O)NCC(=O)N)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C1NC(=O)CC1)CC1NC[NH]C1)CC1C2C([NH]C1)CCCC2)CO)CC1CCC(O)CC1)CC1C2C([NH]C1)CCCC2)CC(C)C)CCCNC(=N)N.

